Developing a Novel Genomic Biomarker for the Early Detection of Neurodegeneration

Abstract

Background: Despite the large and growing global burden of neurodegenerative diseases, it is not currently possible to detect neurodegeneration before irreversible damage to the brain occurs, as this is the point at which clinical symptoms manifest.

The paper